Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Potential complications of combining intramuscular olanzapine with benzodiazepines in emergency department patients.

Wilson MP, MacDonald K, Vilke GM, Feifel D.

J Emerg Med. 2012 Nov;43(5):889-96. doi: 10.1016/j.jemermed.2010.04.012. Epub 2010 Jun 12.

PMID:
20542400
2.

A comparison of the safety of olanzapine and haloperidol in combination with benzodiazepines in emergency department patients with acute agitation.

Wilson MP, MacDonald K, Vilke GM, Feifel D.

J Emerg Med. 2012 Nov;43(5):790-7. doi: 10.1016/j.jemermed.2011.01.024. Epub 2011 May 20.

PMID:
21601409
3.

Olanzapine in ED patients: differential effects on oxygenation in patients with alcohol intoxication.

Wilson MP, Chen N, Vilke GM, Castillo EM, MacDonald KS, Minassian A.

Am J Emerg Med. 2012 Sep;30(7):1196-201. doi: 10.1016/j.ajem.2012.03.013. Epub 2012 May 23.

PMID:
22633728
4.

Intramuscular ziprasidone: influence of alcohol and benzodiazepines on vital signs in the emergency setting.

Wilson MP, MacDonald K, Vilke GM, Ronquillo L, Feifel D.

J Emerg Med. 2013 Dec;45(6):901-8. doi: 10.1016/j.jemermed.2013.07.020. Epub 2013 Sep 24.

PMID:
24071032
5.

A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation.

MacDonald K, Wilson M, Minassian A, Vilke GM, Becker O, Tallian K, Cobb P, Perez R, Galangue B, Feifel D.

J Clin Psychopharmacol. 2012 Jun;32(3):317-22. doi: 10.1097/JCP.0b013e318253a2fe.

PMID:
22544013
6.

A Large Retrospective Cohort of Patients Receiving Intravenous Olanzapine in the Emergency Department.

Martel ML, Klein LR, Rivard RL, Cole JB.

Acad Emerg Med. 2016 Jan;23(1):29-35. doi: 10.1111/acem.12842. Epub 2015 Dec 31.

7.

A retrospective analysis of intramuscular haloperidol and intramuscular olanzapine in the treatment of agitation in drug- and alcohol-using patients.

MacDonald K, Wilson MP, Minassian A, Vilke GM, Perez R, Cobb P, Tallian K, Becker O, Feifel D.

Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):443-5. doi: 10.1016/j.genhosppsych.2010.04.005. Epub 2010 Jun 12.

PMID:
20633750
8.

A Prospective Observational Study of Patients Receiving Intravenous and Intramuscular Olanzapine in the Emergency Department.

Cole JB, Moore JC, Dolan BJ, O'Brien-Lambert A, Fryza BJ, Miner JR, Martel ML.

Ann Emerg Med. 2017 Mar;69(3):327-336.e2. doi: 10.1016/j.annemergmed.2016.08.008. Epub 2016 Nov 4.

PMID:
27823873
9.

Intramuscular haloperidol versus intramuscular olanzapine for treatment of acute agitation: a cost-minimization study.

Freeman DJ, DiPaula BA, Love RC.

Pharmacotherapy. 2009 Aug;29(8):930-6. doi: 10.1592/phco.29.8.930.

PMID:
19637946
10.

Intramuscular olanzapine versus intramuscular aripiprazole for the treatment of agitation in patients with schizophrenia: A pragmatic double-blind randomized trial.

Kittipeerachon M, Chaichan W.

Schizophr Res. 2016 Oct;176(2-3):231-238. doi: 10.1016/j.schres.2016.07.017. Epub 2016 Jul 25.

PMID:
27461399
11.

Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation.

Marder SR, Sorsaburu S, Dunayevich E, Karagianis JL, Dawe IC, Falk DM, Dellva MA, Carlson JL, Cavazzoni PA, Baker RW.

J Clin Psychiatry. 2010 Apr;71(4):433-41. doi: 10.4088/JCP.08m04411gry. Epub 2010 Feb 9.

PMID:
20156413
13.

Intramuscular olanzapine in patients with schizophrenia: an observational study in an emergency room.

Damsa C, Adam E, Lazignac C, De Gregorio F, Mihai A, Lejeune J, Sarasin F, Allen MH.

Bull Soc Sci Med Grand Duche Luxemb. 2008;(2):209-16.

PMID:
18561597
14.

Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation.

Castle DJ, Udristoiu T, Kim CY, Sarosi A, Pidrman V, Omar AN, Rosales JI, Melamed Y, Isik T, Karagianis J, Treuer T.

World J Biol Psychiatry. 2009;10(1):43-53. doi: 10.1080/15622970802688051.

PMID:
19137460
15.

Intramuscular olanzapine vs. intramuscular short-acting antipsychotics: safety, tolerability and the switch to oral antipsychotic medication in patients with schizophrenia or acute mania.

Chandrasena R, Dvoráková D, Lee SI, Loza N, Mosolov SN, Osváth P, Pregelj P, Walton RJ, Karagianis J, Treuer T.

Int J Clin Pract. 2009 Aug;63(8):1249-58. doi: 10.1111/j.1742-1241.2009.02116.x. Epub 2009 Jun 24.

PMID:
19558486
17.

A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patients.

San L, Arranz B, Querejeta I, Barrio S, De la Gándara J, Pérez V.

Eur Psychiatry. 2006 Dec;21(8):539-43. Epub 2006 May 11.

PMID:
16697151
19.

[New formulations of olanzapine in the treatment of acute agitation].

Bartkó G.

Neuropsychopharmacol Hung. 2006 Dec;8(4):171-8. Review. Hungarian.

PMID:
17211052
20.

A double-blind, randomized comparison study of efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in patients with schizophrenia and acute agitated behavior.

Chan HY, Ree SC, Su LW, Chen JJ, Chou SY, Chen CK, Chen YS.

J Clin Psychopharmacol. 2014 Jun;34(3):355-8. doi: 10.1097/JCP.0000000000000120.

PMID:
24743717

Supplemental Content

Support Center